A second wave of infection simply in the absence of an effective new coronavirus vaccine will be inevitable,media BGR reported. Scientists and researchers continue to work around the clock on the new crown candidate vaccine. Just last week,media reported that the U.S. military was working on a coronavirus vaccine that could prove effective against all coronavirus strains. The special vaccine will reportedly begin human testing this summer and, if all goes well, could produce a vaccine as soon as the end of 2020.
However, the first new coronavirus vaccine may not be the universal vaccine we’ve always thought of. As Bloomberg points out, the first new coronavaccineist may not necessarily prevent infection, but will effectively prevent individuals from developing severe symptoms of COVID-19 disease.
At least one of the fastest-moving experimental vaccines has shown an effect on serious diseases in animals – but has entered human trials after less impact on infection. Experts say that if approved, such a product could be widely used, even if that is its contribution until a more effective version is available.
“Vaccines need to prevent disease, not necessarily infection,” said Dennis Burton, an immunologist and vaccine researcher at the Scripps Research Center in La Jolla, California. “
The risk associated with the above vaccine type is that it may cause asymptomatic individuals to inadvertently spread it to others. Of course, if people continue to wear masks and stay at social distance, the risk is greatly reduced. Notably, the World Health Organization (WHO) recently said that asymptomatic transmission of the new coronavirus was not as widespread or widespread as initially thought.
Just last week, Dr Maria Van Kerkhove of the World Health Organization said: “From the data we have, asymptomatic person is actually rarely transmitted to a second person.” “